Blood thinners do not stop the creation of platelets; rather, they typically function by inhibiting coagulation factors (such as thrombin or factor Xa) or by preventing existing platelets from aggregating.
Evidence against · 4
Treatment after transient ischemic attacks: a comparison between anticoagulant drug and inhibition of platelet aggregation.
1983 · cited by 36
This study compares anticoagulants with agents that inhibit platelet aggregation, distinguishing between the coagulation cascade and platelet function.
See more details
More against · 3
Inhibition of factor Xa activity, platelet aggregation, and experimentally induced thrombosis by Sparstolonin B.
2022 · cited by 11
This paper evaluates an agent that targets both factor Xa and platelet aggregation pathways separately rather than suggesting blood thinners stop platelet creation.
Anticoagulant Effects of Albiflorin via Factor Xa Inhibition.
2026 · cited by 1
The study highlights that the agent acts as a direct factor Xa inhibitor while also separately assessing its effects on platelet aggregation.
Anti-Thrombotic Activities of Veratramine via Inhibiting Platelet Aggregation and FIIa/FXa.
2026 · cited by 0
This research shows that the investigated compound exhibits direct dual inhibition of clotting factors alongside the suppression of platelet reactivity and aggregation.